Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Danny N Khalil

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
Hematology/Oncology Clinics of North America|June 2, 2014
Treatments for noncutaneous melanomaDanny N Khalil, Richard D Carvajal
Breast Cancer Research and Treatment|June 23, 2012
Why does Oncotype DX recurrence score reduce adjuvant chemotherapy use?Jeffrey G Schneider, Danny N Khalil
Oncology (Williston Park, N.Y.)|January 22, 2016
Modern Immunotherapy for the Treatment of Advanced Gastrointestinal CancersDanny N Khalil, Neil H Segal
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 13, 2018
Classification of Pancreatic Cancer: Ready for Practical Application?Danny N Khalil, Eileen M O'Reilly
Digestive Diseases and Sciences|March 7, 2019
Biomarkers: What Role Do They Play (If Any) for Diagnosis, Prognosis and Tumor Response Prediction for Hepatocellular Carcinoma?James J Harding, Danny N Khalil, Ghassan K Abou-Alfa
Frontiers in Immunology|April 20, 2019
Targeted APC Activation in Cancer Immunotherapy to Enhance the Abscopal EffectNathan Suek, Luis Felipe Campesato, Taha Merghoub, et al.
Cancer|July 11, 2019
Immune checkpoint inhibitors for hepatocellular carcinomaImane El Dika, Danny N Khalil, Ghassan K Abou-Alfa
Journal of Hepatology|September 23, 2022
Rational development of combination therapies for biliary tract cancersJames J Harding, Danny N Khalil, Luca Fabris, et al.
Nature Reviews. Clinical Oncology|March 16, 2016
The future of cancer treatment: immunomodulation, CARs and combination immunotherapyDanny N Khalil, Eric L Smith, Renier J Brentjens, et al.
Nature Reviews. Clinical Oncology|April 28, 2016
The future of cancer treatment: immunomodulation, CARs and combination immunotherapyDanny N Khalil, Eric L Smith, Renier J Brentjens, et al.
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
Hematology/Oncology Clinics of North America|June 2, 2014
Treatments for noncutaneous melanomaDanny N Khalil, Richard D Carvajal
Breast Cancer Research and Treatment|June 23, 2012
Why does Oncotype DX recurrence score reduce adjuvant chemotherapy use?Jeffrey G Schneider, Danny N Khalil
Oncology (Williston Park, N.Y.)|January 22, 2016
Modern Immunotherapy for the Treatment of Advanced Gastrointestinal CancersDanny N Khalil, Neil H Segal
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 13, 2018
Classification of Pancreatic Cancer: Ready for Practical Application?Danny N Khalil, Eileen M O'Reilly
Digestive Diseases and Sciences|March 7, 2019
Biomarkers: What Role Do They Play (If Any) for Diagnosis, Prognosis and Tumor Response Prediction for Hepatocellular Carcinoma?James J Harding, Danny N Khalil, Ghassan K Abou-Alfa
Frontiers in Immunology|April 20, 2019
Targeted APC Activation in Cancer Immunotherapy to Enhance the Abscopal EffectNathan Suek, Luis Felipe Campesato, Taha Merghoub, et al.
Cancer|July 11, 2019
Immune checkpoint inhibitors for hepatocellular carcinomaImane El Dika, Danny N Khalil, Ghassan K Abou-Alfa
Journal of Hepatology|September 23, 2022
Rational development of combination therapies for biliary tract cancersJames J Harding, Danny N Khalil, Luca Fabris, et al.
Nature Reviews. Clinical Oncology|March 16, 2016
The future of cancer treatment: immunomodulation, CARs and combination immunotherapyDanny N Khalil, Eric L Smith, Renier J Brentjens, et al.
Nature Reviews. Clinical Oncology|April 28, 2016
The future of cancer treatment: immunomodulation, CARs and combination immunotherapyDanny N Khalil, Eric L Smith, Renier J Brentjens, et al.
Pageof 4